“The field could not be more exciting right now to those who are in it,” says infectious-disease specialist Stephen Baum. “But that’s the result of unfortunate developments—bioterrorism, sars, and new forms of influenza that could be extremely dangerous.”
Infectious diseases run the gamut from athlete’s foot to bubonic plague. sars gets the most media attention, but the field’s biggest concern is more mundane: antibiotic resistance. “We’re losing the war on microbes,” says specialist Martin J. Blaser. “What’s needed is a big push to curtail the use of antibiotics. Most sore throats and ear infections don’t need them. If someone has an infection and I prescribe an antibiotic, that prescription affects everyone in his family, his community, the world, living and to be born.” Other specialists agree that the threat is very real. “We’ve treated staph, the world’s No. 1 cause of infection, with penicillin for 50 years,” says James Rahal. “Now it’s resistant. We’ve moved on to vancomycin, usually administered only in the hospital, and now that too is showing signs of resistance.”
And what about SARS? “We’re still very much on the alert,” says Rahal. “If we don’t see anything develop this summer, we need to remain ready for next winter—it’s likely a seasonal virus.” And for the moment, there’s no vaccine on the horizon. “I’m sure there will be one,” says Baum, “but it will be at least a year, more likely two. It takes a year to produce and test a vaccine, even if you know how to do it.”


Woody Harrelson on His Role in Rampart
A New Showrunner Revives Walking Dead
Recalling the First Days of Performance Art
The Met’s Fiery, Six-Hour “Ring” Finale
A Bedroom Built From 20,000 Legos
Look Book: The Designer
Illuminating the Latest Green Lightbulbs
Deli Classics, Perfected at Kutsher's Tribeca
The End of an Era on Wall Street
The Virgin Father of Fifteen Children
A Hip-Hop Blog Becomes an Alterna-YouTube
Why D’Antoni Was Never Right for the Knicks


Join the Discussion
Read All Comments | Add Yours
Recent Comments On This Article